P N Rauk1, U Friebe-Hoffmann. 1. Magee-Womens Research Institute and the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pennsylvania, USA. rsipnr@mail.magee.edu
Abstract
PROBLEM: Intrauterine infection accounts for 20% of preterm labor and results in the production of decidual inflammatory cytokines, including interleukin-1 (IL-1). The oxytocin receptor plays a key role in the onset of preterm labor. Cytokines likely regulate oxytocin receptor expression through several cytokine-induced DNA-binding proteins. METHOD OF STUDY: The objective of this study was to evaluate the effect of the IL-1 alone on oxytocin receptor number as measured by radioligand binding and immunocytochemistry, and oxytocin receptor mRNA as measured by reverse transcriptase-polymerase chain reaction (RT-PCR) in cultured uterine myocytes. RESULTS: Unexpectedly, IL-1 treatment decreased oxytocin receptor number from 111,067 to 23,941 receptors/cell. Loss of oxytocin receptor binding began after 8 hr of IL-1 treatment and was reversible after IL-1 removal. Immunocytochemistry confirmed a loss of cellular oxytocin receptors. Oxytocin receptor mRNA decreased beginning after 2 hr of IL-1 treatment. CONCLUSIONS: IL-1 down-regulates the uterine oxytocin receptor in a time- and dose-dependent fashion.
PROBLEM: Intrauterine infection accounts for 20% of preterm labor and results in the production of decidual inflammatory cytokines, including interleukin-1 (IL-1). The oxytocin receptor plays a key role in the onset of preterm labor. Cytokines likely regulate oxytocin receptor expression through several cytokine-induced DNA-binding proteins. METHOD OF STUDY: The objective of this study was to evaluate the effect of the IL-1 alone on oxytocin receptor number as measured by radioligand binding and immunocytochemistry, and oxytocin receptor mRNA as measured by reverse transcriptase-polymerase chain reaction (RT-PCR) in cultured uterine myocytes. RESULTS: Unexpectedly, IL-1 treatment decreased oxytocin receptor number from 111,067 to 23,941 receptors/cell. Loss of oxytocin receptor binding began after 8 hr of IL-1 treatment and was reversible after IL-1 removal. Immunocytochemistry confirmed a loss of cellular oxytocin receptors. Oxytocin receptor mRNA decreased beginning after 2 hr of IL-1 treatment. CONCLUSIONS:IL-1 down-regulates the uterine oxytocin receptor in a time- and dose-dependent fashion.
Authors: Pooja Mittal; Roberto Romero; Adi L Tarca; Sorin Draghici; Chia-Ling Nhan-Chang; Tinnakorn Chaiworapongsa; John Hotra; Ricardo Gomez; Juan Pedro Kusanovic; Deug-Chan Lee; Chong Jai Kim; Sonia S Hassan Journal: Am J Obstet Gynecol Date: 2011-02 Impact factor: 8.661
Authors: Pooja Mittal; Roberto Romero; Adi L Tarca; Juan Gonzalez; Sorin Draghici; Yi Xu; Zhong Dong; Chia-Ling Nhan-Chang; Tinnakorn Chaiworapongsa; Stephen Lye; Juan Pedro Kusanovic; Leonard Lipovich; Shali Mazaki-Tovi; Sonia S Hassan; Sam Mesiano; Chong Jai Kim Journal: J Perinat Med Date: 2010-07-14 Impact factor: 1.901
Authors: Denis G Baskin; Francis Kim; Richard W Gelling; Brian J Russell; Michael W Schwartz; Gregory J Morton; Hyagriv N Simhan; Daniel H Moralejo; James E Blevins Journal: Endocrinology Date: 2010-07-07 Impact factor: 4.736
Authors: Kate Karelina; Kathleen A Stuller; Brant Jarrett; Ning Zhang; Jackie Wells; Greg J Norman; A Courtney DeVries Journal: Stroke Date: 2011-09-29 Impact factor: 7.914
Authors: Melvyn S Soloff; Yow-Jiun Jeng; Michael G Izban; Mala Sinha; Bruce A Luxon; Susan J Stamnes; Sarah K England Journal: Reprod Sci Date: 2011-08 Impact factor: 3.060
Authors: Stefan Jirecek; Barbara Tringler; Martin Knöfler; Sandra Bauer; Ata Topcuoglu; Christian Egarter Journal: Wien Klin Wochenschr Date: 2003-10-31 Impact factor: 1.704